Lee Ainslie – RCKT history
- Issuer:
- ROCKET PHARMACEUTICALS INC
- Quarters tracked:
- 20 (Q2 2021 → Q1 2026)
- Current shares:
- 3,567,372
- Current value:
- $12.77M
- Peak shares:
- 8,468,344 (Q3 2025)
- Overall change:
- +1952%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 3,567,372 | $12.77M | $3.58 | +1,054,262 | +42% |
| Q4 2025 | 2,513,110 | $8.82M | $3.51 | -5,955,234 | -70% |
| Q3 2025 | 8,468,344 | $27.61M | $3.26 | +104,531 | +1% |
| Q2 2025 | 8,363,813 | $20.49M | $2.45 | +3,164,595 | +61% |
| Q1 2025 | 5,199,218 | $34.68M | $6.67 | +318 | 0% |
| Q4 2024 | 5,198,900 | $65.35M | $12.57 | +1,080,228 | +26% |
| Q3 2024 | 4,118,672 | $76.07M | $18.47 | +190,360 | +5% |
| Q2 2024 | 3,928,312 | $84.58M | $21.53 | +40,000 | +1% |
| Q1 2024 | 3,888,312 | $104.75M | $26.94 | -145,756 | -4% |
| Q4 2023 | 4,034,068 | $120.90M | $29.97 | -1,595,902 | -28% |
| Q3 2023 | 5,629,970 | $115.36M | $20.49 | +1,250,000 | +29% |
| Q2 2023 | 4,379,970 | $87.03M | $19.87 | -27,653 | -1% |
| Q1 2023 | 4,407,623 | $75.50M | $17.13 | +1,011,805 | +30% |
| Q4 2022 | 3,395,818 | $66.46M | $19.57 | +863,452 | +34% |
| Q3 2022 | 2,532,366 | $40.42M | $15.96 | 0 | 0% |
| Q2 2022 | 2,532,366 | $34.84M | $13.76 | +2,532,366 | +100% |
| Q1 2022 | SOLD | — | — | -1,894,966 | -100% |
| Q4 2021 | 1,894,966 | $41.37M | $21.83 | +234,850 | +14% |
| Q3 2021 | 1,660,116 | $49.62M | $29.89 | +1,486,229 | +855% |
| Q2 2021 | 173,887 | $7.70M | $44.29 | — | NEW |